Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted molecular imaging in oncology.

David J Yang1, E Edmund Kim, Tomio Inoue

  • 1Department of Experimental Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston 77030, USA. dyang@di.mdacc.tmc.edu

Annals of Nuclear Medicine
|February 21, 2006
PubMed
Summary

Developing new radiopharmaceuticals enhances tumor imaging for better cancer diagnosis and treatment monitoring. This research focuses on molecular targets for improved cancer detection and therapy using advanced imaging techniques.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contribution of the glossopharyngeal nerve in imidapril-mediated enhancement of the swallowing reflex in rats.

Journal of oral biosciences·2026
Same author

Author Correction: Optogenetic activation of serotonergic neurons changes masticatory movement in freely moving mice.

Scientific reports·2025
Same author

Tooth loss-associated neuroplasticity of mastication-related motor cortical neurons.

Journal of oral biosciences·2024
Same author

Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology.

Pharmaceutics·2024
Same author

Optogenetic activation of serotonergic neurons changes masticatory movement in freely moving mice.

Scientific reports·2024
Same author

Fluoxetine, but not paroxetine, alters the jaw-closing muscle activity during non-rapid eye movement sleep in mice.

Neuroscience research·2024

Area of Science:

  • Nuclear medicine
  • Oncology
  • Radiopharmaceutical chemistry

Background:

  • Scintigraphic tumor imaging relies on developing specific radiopharmaceuticals.
  • Functional pharmaceuticals aid in cancer diagnosis, prognosis, and treatment monitoring.
  • Generator-produced isotopes are key for molecular imaging, therapy, and prevention.

Purpose of the Study:

  • To evaluate novel radiolabeled agents for assessing tumor-specific molecular targets.
  • To explore the potential of 99mTc and 68Ga labeled agents for cancer imaging.
  • To discuss molecular targets in oncology for improved diagnosis and therapeutics.

Main Methods:

  • Synthesis of 99mTc- and 68Ga-labeled agents using ethylenedicysteine (EC) as a chelator.
  • Evaluation of radiolabeled agents for imaging specific tumor targets.

Related Experiment Videos

  • Review of molecular targets in apoptosis, gene-based approaches, angiogenesis, hypoxia, and metabolic imaging.

    • Main Results:

    • 99mTc (SPECT) and 68Ga (PET) labeled agents show potential for tumor imaging.
    • Labeled molecular targets can predict and monitor therapeutic response.
    • Developed imaging ligands have been evaluated in preclinical and clinical studies.

    Conclusions:

    • Novel radiopharmaceuticals targeting molecular pathways improve cancer imaging.
    • 99mTc and 68Ga labeled agents offer versatile tools for SPECT and PET imaging.
    • Targeted molecular imaging holds promise for optimizing cancer diagnosis and treatment.